CClinicalTrials.gg
Status unknownNCT05402501LIMSUpdated Jun 2, 2022

Lifestyle Intervention for Patients With Multiple Sclerosis

An observational study in Multiple Sclerosis, sponsored by Amsterdam UMC, location VUmc. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-06-02.

Sponsored by Amsterdam UMC, location VUmc · Observational

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
900
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The LIMS study is an observational study that investigates the effectiveness of an online lifestyle program for patients with multiple sclerosis (MS). The patients will be monitored during 27 months, starting 3 months prior to the start of the lifestyle program.

Read the detailed description

This study aims to investigate the effect of an online lifestyle program on the impact of multiple sclerosis (MS) on daily functioning. MS patients will participate in the online lifestyle intervention of Voeding Leeft and will complete online questionnaires at 7 time-points: 3 months before the start of the intervention (run-in), before the start of the intervention (baseline), and 3, 6, 12, 18 and 24 months after the start of the intervention. A subsample (n=200) will also take part in measurements through mobile applications. The investigators hypothesize that the lifestyle program will reduce the impact of MS on the patients' daily functioning.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Lifestyle
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 900 is above the median of 100 across 1,016 observational studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Amsterdam UMC, location VUmc is the lead sponsor of 302 studies on the registry; 84 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with multiple sclerosis (MS) who signed up for the online lifestyle intervention of Voeding Leeft will be asked to participate in this observational study.

Eligibility criteria to participate in the online lifestyle intervention:

Inclusion criteria

Inclusion Criteria:

  • MS diagnosis
  • Motivated to adapt their lifestyle
  • Able to complete online questionnaires by themselves
  • Able to do grocery shopping and to (let someone) prepare the meals from the program
  • In a subpopulation (n=200): daily use of a smartphone

Exclusion criteria

Exclusion Criteria:

  • Not able to participate in an online lifestyle intervention (e.g. not having an email address, laptop/computer, internet)
  • An inability to speak or read Dutch
  • Vegan diet
  • Not willing to eat fish
  • BMI \<18.5 and >35 kg/m2
  • Pregnant or breastfeeding
  • Diagnosis of an eating disorder or psychiatric disorder (according to the DSM-V criteria)
  • History of bariatric surgery
  • Another disorder, such as inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis), cardiovascular disease (e.g. severe heart failure), malignancy, diabetes type 1 and 2
  • Having previously participated in a lifestyle intervention of Voeding Leeft or currently participating in another lifestyle program or lifestyle study.
  • Currently under treatment at a dietician or lifestyle coach
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
900 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with multiple sclerosis (MS)

    Patients will participate in an online lifestyle program organized by Voeding Leeft, which consists of four main topics: diet, physical activity, relaxation and sleep.

    Behavioral: Lifestyle intervention program "Leef! met MS"

Interventions

  • BehavioralLifestyle intervention program "Leef! met MS"

    The lifestyle program consists of a three-months intensive program, followed by a 21-months 'inspiration' program with occasional meetings.

06

What researchers measure

Primary outcomes

  1. Multiple Sclerosis Impact Scale (MSIS-29)

    Questionnaire that measures the impact of MS on their daily functioning

    Time frame: Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

Secondary outcomes

  1. 12-item Short Form Health Survey (SF-12)

    Questionnaire that measures quality of life

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  2. EuroQol 5 Dimensions Questionnaire (EQ-5D)

    Questionnaire that measures quality of life

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  3. BMI

    BMI in kg/m\^2

    Time frame: Assessed at 7 time-points during 27 months Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  4. Waist circumference

    Waist circumference in centimeters

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  5. Bristol stool chart

    Tool used to indicate stool type

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  6. Medical Consumption Questionnaire (iMCQ)

    Questionnaire that measures health-care consumption

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  7. Hospital Anxiety and Depression Scale (HADS)

    Questionnaire that measures symptoms of depression and anxiety

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  8. Checklist Individual Strength-20-r (CIS-20)

    Questionnaire that measures the level of fatigue

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  9. Multiple Sclerosis Neuropyschological Screening Questionnaire - patient version (MSNQ-P)

    Questionnaire that measures the level of subjective cognitive complaints

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  10. Medical Outcomes Study Sleep Scale (MOS-ss)

    Questionnaire that measures sleep quality

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  11. Dutch Norm for Healthy Physical Activity (In Dutch: Nederlandse Norm voor Gezond Bewegen (NNGB))

    Questionnaire that measures the level of physical activity

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  12. Perceived stress scale (PSS)

    Questionnaire that measures the level of perceived stress

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  13. iMTA Productivity Cost Questionnaire (iPCQ)

    Questionnaire that measures work productivity and the frequency of sick leave

    Time frame: Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  14. Neurokeys keyboard app

    Only in a subsample (n=200); Real-world keystroke dynamics collected by smartphone technology.

    Time frame: Continuous measures during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  15. MS sherpa app - Smartphone-adapted Symbol Digit Modalities Test (sSDMT)

    Only in a subsample (n=200); Patients will use the MS sherpa app to perform a smartphone-adapted Symbol Digit Modalities Test (sSDMT) on their mobile phone.

    Time frame: Weekly tests during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  16. MS sherpa app - Smartphone-adapted two-minute walking test

    Only in a subsample (n=200); Patients will use the MS sherpa app to perform a two-minute walking test outside.

    Time frame: Weekly tests during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  17. MS sherpa app - questionnaire

    Only in a subsample (n=200); Patients will use the MS sherpa app to answer seven questions on a likert-scale (e.g. about pain, stress, energy, memory) within the mobile application.

    Time frame: Weekly questionnaire during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05402501
Lead sponsor
Amsterdam UMC, location VUmc
Collaborators
National MS Foundation, The Netherlands, Voeding Leeft
Responsible party
Ilse Nauta (Coordinating investigator, Amsterdam UMC, location VUmc) — Principal investigator
First posted
Jun 2, 2022
Start date
Apr 15, 2021
Primary completion
Nov 2024 (estimated)
Completion
Nov 2024 (estimated)
Last update
Jun 2, 2022

Study contacts

Brigit de Jong, Dr.
Contact
b.dejong@amsterdamumc.nl
+31204442834
Ilse Nauta, Drs.
Contact
i.nauta1@amsterdamumc.nl
Brigit de Jong
principal investigator · Amsterdam UMC, location VUmc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion